4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000049
Options or other derivatives
- EVP, Chf Clinical Develop Ofcr acquired 31,545 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-15 | Grant or award : show line 1 in the form Performance Restricted Stock Units | +14,338 | $0.00 | 14,338 | 26,437 | D |
| 2023-01-15 | Grant or award : show line 2 in the form Restricted Stock Unit | +17,207 | $0.00 | 17,207 | 53,116 | D |
Loading xslF345X03/edgardoc.xml…